Literature DB >> 17291293

Epithelia: lymphocyte interactions in the gut.

Stephanie Dahan1, Franziska Roth-Walter, Paul Arnaboldi, Shradha Agarwal, Lloyd Mayer.   

Abstract

The mucosal immune system is governed by a unique set of rules and regulations. The local microenvironment dictates the necessity for these differences. The intestinal epithelial cell (IEC) sits at the interface between an antigen-rich lumen and a lymphocyte-rich lamina propria (LP). The cross talk that occurs between these compartments serves to maintain intestinal homeostasis. IECs have the capacity to talk to LP lymphocytes, activating populations of unique regulatory T cells. These cells have the capacity to talk back to the epithelium, influencing epithelial cell growth and differentiation. This review looks at this cross talk and places it in the context of mucosal immunoregulation.

Mesh:

Year:  2007        PMID: 17291293      PMCID: PMC3864677          DOI: 10.1111/j.1600-065X.2006.00484.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  114 in total

1.  A role for skin gammadelta T cells in wound repair.

Authors:  Julie Jameson; Karen Ugarte; Nicole Chen; Pia Yachi; Elaine Fuchs; Richard Boismenu; Wendy L Havran
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

Review 2.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease.

Authors:  Thomas A Kraus; Lisa Toy; Lisa Chan; Joseph Childs; Lloyd Mayer
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

4.  Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells.

Authors:  H Komano; Y Fujiura; M Kawaguchi; S Matsumoto; Y Hashimoto; S Obana; P Mombaerts; S Tonegawa; H Yamamoto; S Itohara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

5.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

7.  Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation.

Authors:  Bertrand Dubois; Ludivine Chapat; Anne Goubier; Martine Papiernik; Jean-François Nicolas; Dominique Kaiserlian
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

8.  Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo.

Authors:  T R Ulich; E S Yi; K Longmuir; S Yin; R Biltz; C F Morris; R M Housley; G F Pierce
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

10.  Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor.

Authors:  G F Pierce; D Yanagihara; K Klopchin; D M Danilenko; E Hsu; W C Kenney; C F Morris
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  44 in total

1.  Mechanisms of immune tolerance relevant to food allergy.

Authors:  Brian P Vickery; Amy M Scurlock; Stacie M Jones; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

Review 2.  Intestinal epithelial cells in inflammatory bowel diseases.

Authors:  Giulia Roda; Alessandro Sartini; Elisabetta Zambon; Andrea Calafiore; Margherita Marocchi; Alessandra Caponi; Andrea Belluzzi; Enrico Roda
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

3.  Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease.

Authors:  Eran Israeli; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

Review 4.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

Review 5.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

6.  Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis.

Authors:  Lillian Maggio-Price; Audrey Seamons; Helle Bielefeldt-Ohmann; Weiping Zeng; Thea Brabb; Carol Ware; Mingzu Lei; Robert M Hershberg
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

Review 7.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

8.  Epithelial cell microRNAs in gut immunity.

Authors:  Yoshiyuki Goto; Hiroshi Kiyono
Journal:  Nat Immunol       Date:  2011-03       Impact factor: 25.606

Review 9.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

10.  Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD.

Authors:  A Viejo-Borbolla; A P Martin; L R Muniz; L Shang; F Marchesi; N Thirunarayanan; N Harpaz; R A Garcia; M Apostolaki; G C Furtado; L Mayer; G Kollias; A Alcami; S A Lira
Journal:  Mucosal Immunol       Date:  2010-07-21       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.